Literature DB >> 31558766

Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma.

Michael Wang1, Simon Rule2, Pier Luigi Zinzani3, Andre Goy4, Olivier Casasnovas5, Stephen D Smith6, Gandhi Damaj7, Jeanette K Doorduijn8, Thierry Lamy9, Franck Morschhauser10, Carlos Panizo11, Bijal Shah12, Andrew Davies13, Richard Eek14, Jehan Dupuis15, Eric Jacobsen16, Arnon P Kater17, Steven Le Gouill18, Lucie Oberic19, Tadeusz Robak20, Preetesh Jain21, Melanie M Frigault22, Raquel Izumi22, Dorothy Nguyen22, Priti Patel22, Ming Yin22, Monika Długosz-Danecka23.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31558766     DOI： 10.1038/s41375-019-0575-9

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  20 in total

Review 1.  Management of Older Adults with Mantle Cell Lymphoma.

Authors:  Jason T Romancik; Jonathon B Cohen
Journal:  Drugs Aging       Date:  2020-07       Impact factor: 3.923

Review 2.  Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents.

Authors:  Michael J Buege; Anita Kumar; Brianne N Dixon; Laura A Tang; Terry Pak; Jennifer Orozco; Tim J Peterson; Kathryn T Maples
Journal:  Ann Pharmacother       Date:  2020-02-20       Impact factor: 3.154

Review 3.  Sequencing of Novel Therapies for Mantle Cell Lymphoma.

Authors:  Jason T Romancik; Jonathon B Cohen
Journal:  Curr Treat Options Oncol       Date:  2021-11-23

Review 4.  Mantle Cell Lymphoma: the Role of Risk-Adapted Therapy and Treatment of Relapsed Disease.

Authors:  Meri Tarockoff; Teresita Gonzalez; Stanislav Ivanov; Jose Sandoval-Sus
Journal:  Curr Oncol Rep       Date:  2022-05-31       Impact factor: 5.945

Review 5.  The resistance mechanisms and treatment strategies of BTK inhibitors in B-cell lymphoma.

Authors:  Haoran Wang; Wentao Zhang; Jingyi Yang; Keshu Zhou
Journal:  Hematol Oncol       Date:  2021-10-15       Impact factor: 4.850

Review 6.  Emerging therapies in mantle cell lymphoma.

Authors:  Walter Hanel; Narendranath Epperla
Journal:  J Hematol Oncol       Date:  2020-06-17       Impact factor: 17.388

Review 7.  Heat Shock Proteins in Lymphoma Immunotherapy.

Authors:  Zarema Albakova; Yana Mangasarova; Alexander Sapozhnikov
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

Review 8.  Management of Drug Resistance in Mantle Cell Lymphoma.

Authors:  Gaël Roué; Brigitte Sola
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

9.  Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies.

Authors:  Laura Ondrisova; Marek Mraz
Journal:  Front Oncol       Date:  2020-10-26       Impact factor: 6.244

10.  Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.

Authors:  Musa Alzahrani; Mubarak M Al-Mansour; John Apostolidis; Ahmed Barefah; Reyad Dada; Ayman Alhejazi; Yasir Alayed; Ibraheem Motabi; Mansoor Radwi; Hani Al-Hashmi
Journal:  Saudi J Med Med Sci       Date:  2020-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.